Global News

Attunity appoints Lawrence Schwartz as marketing vice president

Wednesday, June 26, 2013 03:17 PM

Attunity, a provider of information availability software solutions, has appointed Lawrence Schwartz as the company’s vice president of marketing. Schwartz will be responsible for marketing and sales enablement. He will focus on driving demand generation and brand awareness as the company positions itself for growth in the data replication and cloud computing markets. Schwartz joins Attunity with 20 years of experience in data and information systems.

More... »

AAHRPP, ViS Research Institute collaborate

Wednesday, June 26, 2013 02:51 PM

The Association for the Accreditation of Human Research Protection Programs (AAHRPP) and the ViS Research Institute have allied to protect research participants by providing easy access to information on the quality and standards of organizations that conduct clinical trials.

More... »

BioClinica introduces StudyView for trials operational visibility

Wednesday, June 26, 2013 02:45 PM

BioClinica, a global provider of clinical trial management solutions, has introduced StudyView, a clinical trials portal and reporting hub that increases clinical trials operational visibility. StudyView provides one tool to access multiple eClinical applications, as well as analyze and report data across studies. Data visualization tools use real-time data for analytics, informing operational decisions about clinical studies. StudyView is fully integrated with BioClinica's product suite and is 21 CFR Part 11 compliant.

More... »

BBK Worldwide launches Google virtual tours as trial enrollment tool

Wednesday, June 26, 2013 02:35 PM

BBK Worldwide, a patient recruitment company, has launched a new online tool that leverages Google virtual tours for patient engagement. The product features 360 degree imaging that provides a virtual tour of locations where clinical research is conducted. This tool offers potential study participants the opportunity to tour the office space in advance, helping set expectations and lessen concerns about participating.

More... »

Grunenthal expands use of BioClinica's Trident

Tuesday, June 25, 2013 12:43 PM

BioClinica, a global provider of clinical trial management solutions, has announced international research-based pharmaceutical Grunenthal will utilize enhancements in Trident IWR/IVR for a global study on pain medication. The three year study will involve 350 patients at 80 sites across 17 countries.

More... »

SCORR Marketing finalist in health care marketing competition

Monday, June 24, 2013 03:47 PM

SCORR Marketing is a finalist in the Medical Marketing and Media (MM&M) Awards, an award competition in the health care marketing industry.

More... »

TWi Biotechnology completes phase II trial patient enrollment

Monday, June 24, 2013 03:44 PM

TWi Biotechnology has completed patient enrollment in a phase II trial of AC-201 for Gout Flare Prophylaxis (GFP) during urate-lowering therapy (ULT). This randomized, double-blind, placebo-controlled phase II study is conducted in eight medical centers in Taiwan and includes patients with acute arthritis of primary gout and elevated serum uric acid. A total of 82 patients were randomized at a 1:1 ratio to receive 50mg AC-201 or placebo twice daily in addition to the ULT during the 16-week treatment period.

More... »

International study on genetic causes of ALS

Monday, June 24, 2013 03:40 PM

The ALS Center in the Netherlands has started an international study into the genetic cause of the fatal disease amyotrophic lateral sclerosis (ALS), also known as motor neurone disease in the U.K. and Lou Gehrig’s disease in the U.S. Researchers in project MinE are collecting, examining and comparing as many DNA profiles as possible from ALS patients as well as from healthy volunteers. The study is being coordinated by the University Medical Center (UMC) Utrecht and is a step for an ALS treatment.

More... »

Parexel launches functional services unit

Monday, June 24, 2013 03:39 PM

Parexel International has announced the launch of Parexel Functional Services within the company's Clinical Research Services business segment.

More... »

Global Awareness Day unites ALS/MND Associations

Monday, June 24, 2013 03:36 PM

The nonprofit ALS Association has joined forces with the International Alliance of ALS/MND Associations for ALS/MND Global Awareness Day. Outside the U.S., amyotrophic lateral sclerosis (ALS) is more commonly known as motor neuron disease or MND.

More... »